| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/29/2009 | US20090030060 Intravaginal treatment of vaginal infections with metronidazole compositions |
| 01/29/2009 | US20090030059 Pharmaceutical composition for external use |
| 01/29/2009 | US20090030058 Tosylate salt of 6- (4-br0m0-2-chl0r0phenylamin0) -7-fluoro-n- (2-hydroxyethoxy) -3-methyl-3h-benzimi dazole- 5 - carboxamide , mek inhibitor useful in the treatment of cancer |
| 01/29/2009 | US20090030057 Pharmaceutical composition of telmisartan |
| 01/29/2009 | US20090030056 Novel sodium channel blockers |
| 01/29/2009 | US20090030055 PKC activation as a means for enhancing sAPPALPHA secretion and improving cognition using bryostatin type compounds |
| 01/29/2009 | US20090030054 Cytoplasmic antigens for detection of candida |
| 01/29/2009 | US20090030052 Pharmaceutical tablet compositions containing irbesartan |
| 01/29/2009 | US20090030051 Inhibitors of IMPDH enzyme |
| 01/29/2009 | US20090030050 Heterocyclic Compounds, Compositions Comprising Them and Methods of Their Use |
| 01/29/2009 | US20090030049 Medicament for genital herpes |
| 01/29/2009 | US20090030048 Novel pharmaceutical compounds |
| 01/29/2009 | US20090030047 Peritoneum protecting agent |
| 01/29/2009 | US20090030046 N-[3-[(2S)-1-methoxypropan-2-yl]oxy-5-(4-methylsulfonylphenoxy)phenyl]-1H-imidazole-5-carboxamide, used as antidiabetic agents, especially for the treatment of non-insulin dependent diabetes |
| 01/29/2009 | US20090030045 Factor xa inhibitors |
| 01/29/2009 | US20090030044 Crystal of Salt of Benzimidazole Compound |
| 01/29/2009 | US20090030043 Potassium Channel Inhibitors |
| 01/29/2009 | US20090030042 Amide Addition Reaction |
| 01/29/2009 | US20090030041 N-substituted N-(4-piperidinyl) Amide Derivative |
| 01/29/2009 | US20090030040 Substituted Heterocyclic Ethers and Their Use in CNS Disorders |
| 01/29/2009 | US20090030039 Piperidine Derivatives as Cxcr3 Receptor Antagonists |
| 01/29/2009 | US20090030038 Novel 8-Sulfonylamino-3 Aminosubstituted Chroman or Tetrahydronaphtalene Derivatives Modulating the 5Ht6 Receptor |
| 01/29/2009 | US20090030037 Sustained Release Formulation and Dosing Schedules of Leukotriene Synthesis Inhibitor for Human Therapy |
| 01/29/2009 | US20090030036 Nuclear receptor binding agents |
| 01/29/2009 | US20090030035 exo-3-(3 ,4-Dichloro-phcnoxy)-8-aza-bicyclo[3.2.1]oct-6-ene; antidepressants, psychological disorders |
| 01/29/2009 | US20090030034 Use of fgf inhibiting substituted 1,2,3 indolizine derivatives in the preparation of medicaments which can be used to treat diseases linked to pathological choroidal angiogenesis |
| 01/29/2009 | US20090030033 Novel Compounds 894 |
| 01/29/2009 | US20090030032 Bicyclic Compound, Production and Use Thereof |
| 01/29/2009 | US20090030031 Method of Preferentially Inducing the Biosynthesis of Interferon |
| 01/29/2009 | US20090030030 Arylalkenyl and arylalkynyl substituted imidazoquinolines |
| 01/29/2009 | US20090030029 Novel benzonaphthyridines |
| 01/29/2009 | US20090030028 Tetrahydroquinolines |
| 01/29/2009 | US20090030027 Androgen Receptor Modulator Compounds and Methods |
| 01/29/2009 | US20090030026 Sustained release formulations of nalbuphine |
| 01/29/2009 | US20090030025 Trans-fused chromenoisoquinolines synthesis and methods for use |
| 01/29/2009 | US20090030023 Pyrimidine compounds and medicinal composition thereof |
| 01/29/2009 | US20090030021 Quinazoline Derivatives and Therapeutic Use Thereof |
| 01/29/2009 | US20090030020 7H-Pyrido[3,4-D]Pyrimidin-8-Ones, Their Manufacture and Use as Protein Kinase Inhibitors |
| 01/29/2009 | US20090030019 Purine derivatives having, in particular, anti-proliferative properties, and their biological uses |
| 01/29/2009 | US20090030018 Benzimidazole derivatives and their use for modulating the gabaalpha receptor complex |
| 01/29/2009 | US20090030017 Therapeutic agent for dyskinesia |
| 01/29/2009 | US20090030016 Benzimidazole poly(adp ribose)polymerase inhibitors |
| 01/29/2009 | US20090030015 Novel multi-cyclic compounds |
| 01/29/2009 | US20090030014 Indole Derivative Having Pgd2 Receptor Antagonist Activity |
| 01/29/2009 | US20090030013 Substituted tetrahydro-quinoline-sulfonamide compounds, their preparation and use as medicaments |
| 01/29/2009 | US20090030012 Pyridine, Pyrimidine and Pyrazine Derivatives as Cxcr3 Receptor Modulators |
| 01/29/2009 | US20090030011 1-Aminocarbonyl-, 1-aminosulfoxyl- and 1-aminosulfonyl-substituted triazolopyridines, e.g., 5-chloro-[1,2,3]triazolo[4,5-b]pyridin-1-yl)-(3,4-dihydro-1H-isoquinolin-2-yl)-methanone; these compounds lower triglyceride levels and are used to prevent and treat type II diabetes and arteriosclerosis |
| 01/29/2009 | US20090030010 3-Amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents |
| 01/29/2009 | US20090030009 Heterobicyclic Carboxamides as Inhibitors for Kinases |
| 01/29/2009 | US20090030008 Piperazine derivatives and their use as therapeutic agents |
| 01/29/2009 | US20090030007 crystalline form of trans-1 {4-[2-[4-(2,3-dichlorophenyl)-piperazin-1-yl]-ethyl]-cyclohexyl}-3,3-dimethyl-urea hydrochloride (Form III) Cariprazine {RGH-188); Dysfunction of the dopaminergic neurotransmitter system is involved in the pathology of several neuropsychiatric and neurodegenerative disorders |
| 01/29/2009 | US20090030006 sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor; 1,1-anhydro-1-C-[5-(4-ethylphenyl)methyl-2-(hydroxymethyl)phenyl]- beta -D-glucopyranose, for example |
| 01/29/2009 | US20090030005 Combinations for the treatment of cancer |
| 01/29/2009 | US20090030004 Specific salt, anhydrous and crystalline form of a dihydropteridione derivative |
| 01/29/2009 | US20090030003 Amino-heterocyclic compounds |
| 01/29/2009 | US20090030002 Heterocyclic compounds and their uses |
| 01/29/2009 | US20090030001 Therapeutic agent for corneal disease |
| 01/29/2009 | US20090030000 Antiviral agents |
| 01/29/2009 | US20090029999 Synephrine derivatives useful as anti-inflammatory agents |
| 01/29/2009 | US20090029998 Thiazole Derivatives and Use Thereof |
| 01/29/2009 | US20090029997 Thiazole Derivatives and Use Thereof |
| 01/29/2009 | US20090029996 Pyridazin-3(2H)-One Derivatives And Their Use As Pde4 Inhibitors |
| 01/29/2009 | US20090029995 Hetero biaryl derivatives as matrix metalloproteinase inhibitors |
| 01/29/2009 | US20090029994 Trisubstituted amine compound |
| 01/29/2009 | US20090029993 Methods of affecting gastrointestinal transit and gastric emptying, and compounds useful therein |
| 01/29/2009 | US20090029992 Substituted pyrazole compounds |
| 01/29/2009 | US20090029991 Benzamide derivatives useful as histone deacetylase inhibitors |
| 01/29/2009 | US20090029990 Dihydropteridinones in the treatment of respiratory diseases |
| 01/29/2009 | US20090029989 Substituted pyrazolopyrimidines |
| 01/29/2009 | US20090029988 Hydroxyalkyl Substituted Imidazoquinolines |
| 01/29/2009 | US20090029987 Pharmaceutical Compositions for the Prevention and Treatment of Complex Diseases and Their Delivery by Insertable Medical Devices |
| 01/29/2009 | US20090029986 such as 1-{(S)-2-[(5-Bromo-pyrimidin-2-ylamino)-methyl]-piperidin-1-yl}-1-quinolin-2-yl-methanone, used as human orexin receptor antagonist, for the treatment of obesity and insomnia |
| 01/29/2009 | US20090029985 Pyridazine compounds and methods |
| 01/29/2009 | US20090029984 Synergistic combination for the treatment of pain (cannabinoid receptor agonist and opioid receptor agonist) |
| 01/29/2009 | US20090029983 Novel heterocyclic compounds having anti-hbv activity |
| 01/29/2009 | US20090029982 Protein kinase inhibitors |
| 01/29/2009 | US20090029981 Substituted 4-phenylpiperidines |
| 01/29/2009 | US20090029980 C-7 Isoxazolinyl Quinolone / Naphthyridine Derivatives Useful as Antibacterial Agents |
| 01/29/2009 | US20090029979 5-htx modulators |
| 01/29/2009 | US20090029978 Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity |
| 01/29/2009 | US20090029977 Dual modulators of 5ht2a and d3 receptors |
| 01/29/2009 | US20090029976 e.g. [5-(1-cyclobutyl-piperidin-yloxy)-benzofuran-2-yl]-(4,4-difluoro-piperidin-1-yl)-methanone; antagonists and/or inverse agonists at the histamine 3 receptor (H3 receptor); antidepressant, antiepileptic agent, analgesic, anticonvulsant, motion seackness |
| 01/29/2009 | US20090029975 1,3-benzothiazinone derivative and use thereof |
| 01/29/2009 | US20090029974 Tumor Treatment with Gliotoxin Derivatives |
| 01/29/2009 | US20090029973 growth factor receptor tyrosine kinase inhibitor; anticarcinogenic agents; N-{2-[4-({3-chloro-4-[3-(trifluoromethyl)phenoxy]phenyl}amino)-5H-pyrrolo[3,2-d]pyrimidin-5-yl]ethyl}-3-hydroxy-3-methylbutanamide |
| 01/29/2009 | US20090029972 Dibenzodiazepinone Analogues, Processes for Their Production and Their Use as Pharmaceuticals |
| 01/29/2009 | US20090029971 4-[2,6-Dimethyl-4-(4-trifluoromethoxy-phenyl)-piperazine-1-sulfonyl]-indan-2-carboxylic acid; peroxisome proliferator activated receptors modulator; antidiabetic, antiinflammatory agent; obesity, hyperinsulinemia, metabolic syndrome X, polycystic ovary syndrome, ischemia-associated organ injury |
| 01/29/2009 | US20090029970 Pain remedy containing rock inhibitor |
| 01/29/2009 | US20090029969 1-(2,4-dichlorophenyl)-4-methyl-5-(5-(pent-1-enyl)thiophen-2-yl)-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide; cannabinoid receptor modulator; liver fibrosis, obesity, type II diabetes, atherosclerosis, analgesia, haemorrhagic shock, ischemia, liver cirrhosis, neurodegenerative diseases |
| 01/29/2009 | US20090029968 Quinazoline derivatives used as inhibitors of erbb tyrosine kinase |
| 01/29/2009 | US20090029967 Adenosine a2a receptor antagonists for the treatment of extra-pyramidal syndrome and other movement disorders |
| 01/29/2009 | US20090029966 Combination therapy with parp inhibitors |
| 01/29/2009 | US20090029965 Vasopressin V1a Antagonists |
| 01/29/2009 | US20090029964 Novel carbapenem compound |
| 01/29/2009 | US20090029963 Pyrazol derivatives |
| 01/29/2009 | US20090029962 2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as taar-ligands |
| 01/29/2009 | US20090029961 Bio-Film Resistant Surfaces |
| 01/29/2009 | US20090029960 Macrocyclic compounds useful as base inhibitors |
| 01/29/2009 | US20090029959 Antiglucocorticoid Therapy for the Prevention of Neurological Damage in Premature Infants |
| 01/29/2009 | US20090029958 Phenethanolamine derivatives as beta2 adrenoreceptor agonists |